Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00663) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Satraplatin
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Drug in Phase 3 Clinical Trial
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=6918220"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Cytochrome P450 2C8 (CYP2C8) | DME Info | Homo sapiens | [1] | |||
| Cytochrome P450 2E1 (CYP2E1) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | Toxicity, recovery, and resilience in a 3D dopaminergic neuronal in vitro model exposed to rotenone. Arch Toxicol. 2018 Aug;92(8):2587-2606. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.